~~<i id='15D10CF3BA'><strike id='15D10CF3BA'><tt id='15D10CF3BA'><pre id='15D10CF3BA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

comprehensive

author：entertainment 2025-09-03 09:22:11 - browse：538

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met.

AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Health officials lay out plans to cope with respiratory virus season

knowledge

hotspot

entertainment

hotspot

knowledge

explore

MahmoudIllean/APOfthe103millionconfirmedcasesofCovid-19intheU.S.,anestimatedone-thirdhaveledtolongCo

WSS

CDC Director Mandy Cohen on transparency, trust, and health

Will the FTC rein in IQVIA's health data empire?

Why patients can’t get everything they want on drug pricing

Can U.S. cancer drug shortages be fixed?

Search called off for baby washed away in Pennsylvania flash flood

Vivek Ramaswamy made waves in the debate, much as in biotech

Wikipedia

comprehensive

knowledge

The high cost of giving birth even with insurance

Why patients can’t get everything they want on drug pricing

Hepatitis C has a cure — but many Americans still lack access to it

Senate panel puts off hardest PBM reforms for another day

Novavax promises a turnaround & Lilly roils the obesity market

Meadows told special counsel he could not recall Trump ever declassifying Mar

Supreme Court strikes down use of affirmative action

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Affirmative action in medical school literally saved lives

Former Pear Therapeutics executives start new VC firm

hotspot

Intellia plays down concerns on accidental germline transmission

National associations that represent hospice owe an apology

Roche's accidental data boosts hopes for anti

A new crop of companies is reshaping the health data economy

Can U.S. cancer drug shortages be fixed?

People can get long Covid without testing positive for virus: Study

entertainment

hotspot

knowledge

explore